Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

MESNEX

MESNA

Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MESNEX is listed in Drugs@FDA under application 019884 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MESNA Form and strength INJECTABLE;INTRAVENOUS - 100MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-12-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview MESNEX is listed in Drugs@FDA under application 019884 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MESNA Form and strength INJECTABLE;INTRAVENOUS - 100MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-12-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.